A Suffolk County jury has awarded $8M in favor of Janice Paluzzi, a Massachusetts woman who developed mesothelioma after decades of using Johnson & Johnson’s talcum powder products. The jury found the company liable for negligence and breach of warranty, concluding that the company’s asbestos-contaminated talcum powder products caused Paluzzi’s terminal cancer. J&J ceased production and sale of all products containing talc in the United States in 2020. Ms. Paluzzi was diagnosed with mesothelioma in 2021.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Trump administration weighs crackdown on pharma ads, Bloomberg says
- Johnson & Johnson call volume above normal and directionally bullish
- Johnson & Johnson announces new results from Phase 2 RedirecTT-1 study
- Johnson & Johnson announces clinical data from Phase 1b study of JNJ-4496
- Strategic Positioning and Growth Potential Drive Buy Rating for Johnson & Johnson